** Torrent Pharma TORP.NS rises 5.9% to record high of 3,809 rupees; set for biggest single-day pct gain since May 2023
** Drugmaker's Q2 profit jumps 30.5% y/y, driven by strong domestic demand for its cardiovascular, anti-diabetic drugs
** Revenue grows 12% y/y on higher domestic sales, accounting for more than half of total
** JP Morgan cites growth driving Indian market, recovery in Brazil, potential semaglutide launch next year, JB Pharma deal synergies as multiple catalysts for co
** Jefferies says co "gold standard of consistency" given its domestic-focused approach with steady, predictable growth
** Maintains "buy"; raises PT by 100 rupees to 4,300 rupees
** More than 704,000 shares traded, 3x their 30-day avg
** Stock rated "buy" on avg; median PT is 4,000 rupees, per data compiled by LSEG
** YTD, TORP gains 13.4%
(Reporting by Urvi Dugar in Bengaluru)
((UrviManoj.Dugar@thomsonreuters.com;))